Dare Bioscience, Inc. Common Stock
€1.861
EUR
Last updated on --.
24h volume129.39K
24h highest1.9161 EUR
24h lowest1.7157 EUR
24h Price movement+5.61%
DARE recent prices
24 Hours
+5.61%+€0.0989
30 days
-37.16%-€1.045
60 days
+13.54%+€0.2107
90 days
+34.31%+€0.4515
Key data
Previous close1.7630 EUR
Market cap28.73M EUR
Volume129.39K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.68800 EUR
Net income (FY)-10.34M EUR
Revenue (FY)995.21K EUR
Last report dateMay 14, 2026
About Dare Bioscience, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)24.00
Revenue per employee (FY)41.47K EUR
Net income per employee (FY)-430.75K EUR
Listed onNasdaq
DARE conversion tables
 |  |
|---|---|
| 0.5 DARE | 0.93095 EUR |
| 1 DARE | 1.861 EUR |
| 5 DARE | 9.309 EUR |
| 10 DARE | 18.61 EUR |
| |
|---|---|
| 0.5 EUR | 0.26854 DARE |
| 1 EUR | 0.53709 DARE |
| 5 EUR | 2.685 DARE |
| 10 EUR | 5.370 DARE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
DARE is trading at €1.861, +5.61% over the last 24 hours. Track live moves on the price chart at the top of this page.
The DARE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. DARE is currently trading at €1.861, +5.61% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on DARE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. DARE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from DARE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against DARE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Dare Bioscience, Inc. Common Stock's market cap is currently 28.73M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume129.39K
24h highest1.9161 EUR
24h lowest1.7157 EUR
24h Price movement+5.61%
Start trade with DARE Perpetual
Sign up to trade